Risk factors for adverse clinical outcomes in patients with tubo-ovarian abscess

References

• Chen MJ, Yang JH, Yang YS, Ho HN. 2004. Increased occurrence of tubo-ovarian abscesses in women with stage III and IV endometriosis. Fertil Steril 82:498–499.
   PubMed Web of Science ®Google Scholar
• Dewitt J, Reining A, Allsworth JE, Peipert JF. 2010. Tuboovarian abscesses: is size associated with duration of hospitalization & complications? Obstetrics and Gynecology International 2010:847041.
   PubMedGoogle Scholar
• Gagliardi PD, Hoffer PB, Rosenfield AT. 1988. Correlative imaging in abdominal infection: an algorithmic approach using nuclear medicine, ultrasound, and computed tomography. Seminars in Nuclear Medicine 18:320–334.
   PubMed Web of Science ®Google Scholar
• Ginsburg DS, Stern JL, Hamod KA, Genadry R, Spence MR. 1980. Tubo-ovarian abscess: a retrospective review. American Journal of Obstetrics and Gynecology 138:1055–1058.
   PubMed Web of Science ®Google Scholar
• Gjelland K, Ekerhovd E, Granberg S. 2005. Transvaginal ultrasound-guided aspiration for treatment of tubo-ovarian abscess: a study of 302 cases. American Journal of Obstetrics and Gynecology 193:1323–1330.
   PubMed Web of Science ®Google Scholar
• Hager WD, Eschenbach DA, Spence MR, Sweet RL. 1983. Criteria for diagnosis and grading of salpingitis. Obstetrics and Gynecology 61: 113–114.
   PubMed Web of Science ®Google Scholar
• Hsiao SM, Hsieh FJ, Lien YR. 2006. Tuboovarian abscesses in postmenopausal women. Taiwanese Journal of Obstetrics and Gynecology 45: 234–238.
   PubMedGoogle Scholar
• Jackson SL, Soper DE. 1999. Pelvic inflammatory disease in the postmenopausal woman. Infectious Diseases in Obstetrics and Gynecology 7: 248–252.
   PubMedGoogle Scholar
• Jaiyeoba O, Lazenby G, Soper DE. 2011. Recommendations and rationale for the treatment of pelvic inflammatory disease. Expert Review of Anti-infective Therapy 9:61–70.
   PubMed Web of Science ®Google Scholar
• Kubota T, Ishi K, Takeuchi H. 1997. A study of tubo-ovarian and ovarian abscesses, with a focus on cases with endometrioma. Journal of Obstetrics and Gynaecology Research 23:421–426.
   PubMedGoogle Scholar
• Landers DV, Sweet RL. 1983. Tubo-ovarian abscess: contemporary approach to management. Reviews of Infectious Diseases 5:876–884.
   PubMedGoogle Scholar
• Lipscomb GH, Ling FW. 1992. Tubo-ovarian abscess in postmenopausal patients. Southern Medical Journal 85:696–699.
   PubMed Web of Science ®Google Scholar
• Mizushima T, Yoshida H, Ohi Y, Ishikawa M, Hirahara F. 2013. Evaluating the risk factors for developing resistance to parenteral therapy for tubo-ovarian abscess: a case-control study. Journal of Obstetrics and Gynaecology Research 39:1019–1023.
   PubMed Web of Science ®Google Scholar
• Ness RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL et al. 2002. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. American Journal of Obstetrics and Gynecology 186:929–937.
   PubMed Web of Science ®Google Scholar
• Newkirk GR. 1996. Pelvic inflammatory disease: a contemporary approach. American Family Physician 53:1127–1135.
   PubMed Web of Science ®Google Scholar
• Protopapas AG, Diakomanolis ES, Milingos SD, Rodolakis AJ, Markaki SN, Vlachos GD, et al. 2004. Tubo-ovarian abscesses in postmenopausal women: gynecological malignancy until proven otherwise? European Journal of Obstetrics and Gynecology and Reproductive Biology 114:203–209.
   PubMed Web of Science ®Google Scholar
• Reed SD, Landers DV, Sweet RL. 1991. Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens. American Journal of Obstetrics and Gynecology 164:1556–1561;discussion 1561–1562.
   PubMed Web of Science ®Google Scholar
• Soper DE, Brockwell NJ, Dalton HP, Johnson D. 1994. Observations concerning the microbial etiology of acute salpingitis. American Journal of Obstetrics and Gynecology 170:1008–10014; discussion 1014–1017.
   PubMed Web of Science ®Google Scholar
• Sweet RL, Schachter J, Landers DV, Ohm-Smith M, Robbie MO. 1988. Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline. American Journal of Obstetrics and Gynecology 158: 736–741.
   PubMed Web of Science ®Google Scholar
• Terao M, Koga K, Fujimoto A, Wada-Hiraike O, Osuga Y, Yano T et al. 2014. Factors that predict poor clinical course among patients hospitalized with pelvic inflammatory disease. American Journal of Obstetrics and Gynecology 40:495–500.
   Google Scholar
• Timor-Tritsch IE, Lerner JP, Monteagudo A, Murphy KE, Heller DS. 1998. Transvaginal sonographic markers of tubal inflammatory disease. Ultrasound in Obstetrics and Gynecology 12:56–66.
   PubMed Web of Science ®Google Scholar
• Wasserheit JN, Bell TA, Kiviat NB, Wolner-Hanssen P, Zabriskie V, Kirby B et al. 1986. Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Annals of Internal Medicine 104:187–193.
   PubMed Web of Science ®Google Scholar
• Wiesenfeld HC, Sweet RL. 1993. Progress in the management of tuboovarian abscesses. Clinical Gynecology and Obstetrics 36:433–444.
   PubMed Web of Science ®Google Scholar
• Workowski KA, Berman S. 2010. Centers for disease control prevention, sexually transmitted diseases treatment guidelines, 2010. MMWR Recommendations and Reports 59:1–110.
   PubMedGoogle Scholar